AML With Monocytic Differentiation
1 clinical trials · Condition
◉ Watch AML With Monocytic Differentiation
| Record | Firm | Date |
|---|---|---|
| IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML (NCT04372433) | Immune-Onc Therapeutics | 2020-09-14 |
Track AML With Monocytic Differentiation automatically
Every clearance here is in the API, with alerts when new ones post.